SAN DIEGO, Calif. – Three early-phase clinical studies presented by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2024 show promising initial data for patients with lymphoma, gastric or gastroesophageal junction cancers, and specific molecularly selected tumors. The...
Latest News
SAN DIEGO, Calif. — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study in Cancers from The University of Texas MD Anderson Cancer Center showing how optical genome mapping (OGM) can address key limitations of targeted RNA-sequencing (RNA-seq) panels in detecting therapeutically-relevant gene rearrangements in acute leukemias. This peer-reviewed...
Phase I trial demonstrates lasting responses and encouraging safety profile in two aggressive thyroid cancer subtypes, suggesting further progress for CAR T cell therapy in solid tumors One patient experienced a complete response, and one patient had a partial response This type of cancer has limited treatment options, and...
NEW YORK – The Muscular Dystrophy Association (MDA) has selected Keisha Greaves from Cambridge, Massachusetts, to represent families living with muscular dystrophy and related neuromuscular diseases alongside current National Ambassador eleven-year-old Ethan LyBrand of Decatur, Alabama. “I have been involved with MDA because muscular dystrophy is now a part of me,” said Keisha. “I feel like it is...
BUFFALO, NY – A new research paper was published in Genes & Cancer entitled, “Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis.” Hepatocellular carcinoma (HCC) is the third leading cause of death from cancer worldwide but is often diagnosed at...
BOSTON, Mass. and KANSAS CITY, Kan. — Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, and its clinical development division Sardocor, together with the University of Kansas Medical Center, today announced the successful treatment of the first patient in the MUSIC-DMD Phase...
ISTANBUL — Zeynep Liva Elmacı, a dystonia patient who has been having uncontrollable involuntary contractions in her legs and arms for the last 5 years, underwent brain pacemaker surgery while awake by watching cartoons. The patient’s surgery was performed Medical Park, Turkey’s health power with 27 Hospitals and thousands of...
Charleston, SC – As the years add up, it’s common to notice slight changes in our ability to remember and think. Older people who have more marked changes than their peers can be diagnosed with mild cognitive impairment (MCI). Currently, we can’t easily predict which of these patients will develop...
TORONTO, Canada and HOUSTON, TX — Medicenna Therapeutics Corp., a clinical-stage immunotherapy company focused on the development of Superkines, today announced initiation of enrollment in the combination arm of the Phase 1/2 ABILITY (ABeta-only IL-2 ImmunoTherapY) study evaluating MDNA11, a long-acting, “beta-enhanced not-alpha” interleukin-2 (IL-2) super-agonist, with Merck’s pembrolizumab (KEYTRUDA®)....
I blog, I tweet and I use Facebook. And as I recently told a medical colleague, social media has been an enormously useful tool in my work. “I can barely keep up with e-mail,” he snorted back. “I’m not about to open up that black box.” About 15 years ago,...